Protocol No.: NRG-GY009

Title
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolozumab versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer
Principal Investigator
Galvan Turner, Valerie
Phase
II/III
Age Group
Adult
Applicable Disease Site
Gynecologic Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Deborah Moore, MS
Research Specialist
Phone: +1 304-293-0609

View on ClinicalTrials.gov